BIOREGENX, INC. BRGX revenue by segment, product and geography
In its fiscal year ending 2025-12-31, BIOREGENX, INC. reported revenue across 4 products and services; the largest, Nutritional, was $1.63M, 87.4% of the filed sum (-10.8% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Nutritional$1.63M87.4%-10.8% yoy
- Medical Testing$208K11.2%-64.6% yoy
- Wellness Devices$25.4K1.4%-86.4% yoy
- Other Sales$8840.0%-72.4% yoy
Members sum to the consolidated $1.85M for this period.
- Nutritional$385K90.2%-17.7% yoy
- Medical Testing$33.8K7.9%-30.3% yoy
- Wellness Devices$9.8K2.3%+97860.0% yoy
- Other Returns-$2.01K-0.5%+116.5% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.